Alzheimer’s is a devastatingly progressive disease that robs our loved ones of their memories and personalities. Presently 5.7 million Americans are living with Alzheimer’s. By 2050, this number is projected to rise to nearly 14 million. Early and accurate diagnosis could save up to $7.9 trillion in medical and care costs, according to the Alzheimer’s Association. There is increasing evidence that Alzheimer’s disease lies on a continuum with dynamic neurobiological and pathological symptoms. As the disease progresses, targeting specific therapeutic windows for intervention may give patients